[The Yeast Fungus Malassezia: Pathogen, Pathogenesis and Therapy]

Hautarzt. 2001 Jan;52(1):73-86. doi: 10.1007/s001050051268.
[Article in German]

Publication types

  • Comparative Study
  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy
  • Adolescent
  • Adult
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Child
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy
  • Dermatitis, Atopic / etiology
  • Dermatitis, Seborrheic / diagnosis
  • Dermatitis, Seborrheic / drug therapy
  • Dermatitis, Seborrheic / etiology
  • Dermatomycoses* / diagnosis
  • Dermatomycoses* / drug therapy
  • Dermatomycoses* / etiology
  • Diagnosis, Differential
  • Female
  • Folliculitis / diagnosis
  • Folliculitis / drug therapy
  • Folliculitis / etiology
  • Humans
  • Ketoconazole / pharmacology
  • Ketoconazole / therapeutic use
  • Malassezia* / drug effects
  • Malassezia* / isolation & purification
  • Male
  • Naphthalenes / pharmacology
  • Naphthalenes / therapeutic use
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Scalp Dermatoses / etiology
  • Terbinafine
  • Tinea Versicolor* / diagnosis
  • Tinea Versicolor* / drug therapy
  • Tinea Versicolor* / etiology

Substances

  • Antifungal Agents
  • Naphthalenes
  • Pyridones
  • rilopirox
  • Terbinafine
  • Ketoconazole